Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation

[1]  A. Ma,et al.  A20: A multifunctional tool for regulating immunity and preventing disease. , 2019, Cellular immunology.

[2]  G. Kollias,et al.  A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain , 2019, Nature Cell Biology.

[3]  M. McDermott,et al.  Faculty Opinions recommendation of A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[4]  P. Miossec,et al.  IL-17 in Rheumatoid Arthritis and Precision Medicine: From Synovitis Expression to Circulating Bioactive Levels , 2019, Front. Med..

[5]  A. Blauvelt,et al.  The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis , 2018, Clinical Reviews in Allergy & Immunology.

[6]  I. Touitou,et al.  Autosomic dominant familial Behçet disease and haploinsufficiency A20: A review of the literature. , 2018, Autoimmunity reviews.

[7]  N. Hacohen,et al.  Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry , 2018, bioRxiv.

[8]  D. Veale,et al.  The pathogenesis of psoriatic arthritis , 2018, The Lancet.

[9]  I. Touitou,et al.  ‘A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease’ , 2018, Annals of the rheumatic diseases.

[10]  D. Kastner,et al.  A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease , 2018, Annals of the rheumatic diseases.

[11]  O. Ohara,et al.  Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. , 2017, The Journal of allergy and clinical immunology.

[12]  A. Ma,et al.  Hypomorphic A20 expression confers susceptibility to psoriasis , 2017, PloS one.

[13]  J. Orange,et al.  Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease , 2016, Proceedings of the National Academy of Sciences.

[14]  Jinfeng Liu,et al.  Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation , 2015, Nature.

[15]  J. Mullikin,et al.  Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early onset autoinflammatory syndrome , 2015, Nature Genetics.

[16]  K. Rittinger,et al.  LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes , 2015, Cell reports.

[17]  H. Hammad,et al.  Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells , 2015, Science.

[18]  A. Burlingame,et al.  The ubiquitin-modifying enzyme A20 restricts the ubiquitination of RIPK3 and protects cells from necroptosis , 2015, Nature Immunology.

[19]  A. Burlingame,et al.  A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity. , 2015, Immunity.

[20]  Arnab De,et al.  The deubiquitinase activity of A20 is dispensable for NF‐κB signaling , 2014, EMBO reports.

[21]  G. van Loo,et al.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.

[22]  C. Huttenhower,et al.  Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis , 2013, eLife.

[23]  Patrick G. A. Pedrioli,et al.  Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains , 2013, Proceedings of the National Academy of Sciences.

[24]  George Kollias,et al.  Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells , 2013, Annals of the rheumatic diseases.

[25]  Hao Wu,et al.  Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. , 2013, Immunity.

[26]  I. Dikic,et al.  A20 inhibits LUBAC‐mediated NF‐κB activation by binding linear polyubiquitin chains via its zinc finger 7 , 2012, The EMBO journal.

[27]  H. Nishimasu,et al.  Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF‐κB regulation , 2012, The EMBO journal.

[28]  Jin He,et al.  Direct, noncatalytic mechanism of IKK inhibition by A20. , 2011, Molecular cell.

[29]  E. Huang,et al.  Dendritic cell expression of A20 preserves immune homeostasis and prevents colitis and spondyloarthritis , 2011, Nature Immunology.

[30]  M. Kool,et al.  A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis , 2011, Nature Genetics.

[31]  H. Hammad,et al.  The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. , 2011, Immunity.

[32]  V. Dixit,et al.  Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. , 2010, Molecular cell.

[33]  C. Liu,et al.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. , 2010, Immunity.

[34]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[35]  Noula Shembade,et al.  Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes , 2010, Science.

[36]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[37]  Yusuke Sato,et al.  Structural basis for specific recognition of Lys 63‐linked polyubiquitin chains by tandem UIMs of RAP80 , 2009, The EMBO journal.

[38]  Joshua J. Sims,et al.  Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of rap80. , 2009, Molecular cell.

[39]  D. Baltimore,et al.  The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules , 2009, Nature Immunology.

[40]  Bettina L. Lee,et al.  Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20 , 2008, The Journal of experimental medicine.

[41]  George Kollias,et al.  Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases , 2008, The Journal of experimental medicine.

[42]  Y. Lo,et al.  Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. , 2008, Journal of molecular biology.

[43]  S. Gabriel,et al.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis , 2007, Nature Genetics.

[44]  Georg Schett,et al.  Cytokines in the pathogenesis of rheumatoid arthritis , 2007, Nature Reviews Immunology.

[45]  Matthew T Wheeler,et al.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.

[46]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[47]  D. Wallach.  Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. , 2004 .

[48]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[49]  A. Ma,et al.  Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.

[50]  J. Woody,et al.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.

[51]  D. Gladman,et al.  Psoriatic Arthritis. , 2017, The New England journal of medicine.

[52]  L. Catrysse,et al.  A20 in inflammation and autoimmunity. , 2014, Trends in immunology.

[53]  A. R.,et al.  Review of literature , 1969, American Potato Journal.

[54]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[55]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.